AstraZeneca bets up to $443M on Omthera lipid drug

Pipeline-starved AstraZeneca ($AZN) snapped up Omthera ($OMTH) in a deal worth up to $443 million, on hopes for the company's omega-3 cardio drug Epanova. Report